Hypercompressed pharmaceutical formulations
作者： Libin Barry M , Liebmann Jeffrey M , Chen Weiliam
DOI:
关键词:
摘要: A pharmaceutical dosage form which comprises a lactide, glycolide or lactide-glycolide polymer, block polymer of polyglycolide, trimethylene carbonate, poly-caprolactone, and polyethylene oxide that is combined with peptide protein therapeutic agent in the microparticles are compressed using pressure 50,000 to 350,000 psi.
lens.org 参考文章(16)
David A. Marsh, Hongwen Ma Rivers, Time released biodegradable or bioerodible microspheres or microparticles suspended in a solidifying depot-forming injectable drug formulation ,(2013)
Barry M. Libin, Jeffrey M. Liebmann, Weiliam Chen, Controlled release implantable dispensing device and method ,(2009)
Hanshermann Franke, Peter Lennartz, Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release ,(2003)
Brian A. Leuthner, R. Loch Macdonald, Drug delivery system for the prevention of cerebral vasospasm ,(2008)
Guenter Kraus, Iksoo Chun, Qiang Zhang, Lieven Elvire Colette Baert, Deborah M. Schachter, Degradable removable implant for the sustained release of an active compound ,(2010)
Jia-Hwa Fang, Maninder Hora, Derek O'hagan, Manmohan Singh, Microparticle compositions and methods for the manufacture thereof ,(2001)
Heribert Bohn, Helmut Auweter, Joerg Breitenbach, Robert Heger, Nanoparticulate core-shell systems and use thereof in pharmaceutical and cosmetic preparations ,(1999)
Li Yuhua, Benjamin Chien, Pharmaceutical compositions for controlled release delivery of biologically active compounds ,(2005)
Piero Orsolini, Method for preparing a pharmaceutical composition in the form of microparticles ,(1990)
Piergiorgio Gentile, Valeria Chiono, Irene Carmagnola, Paul Hatton, An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based Biomaterials for Bone Tissue Engineering International Journal of Molecular Sciences. ,vol. 15, pp. 3640- 3659 ,(2014) , 10.3390/IJMS15033640